ArticleNPJ breast cancer2025

A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer.

Hatem Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.